OMERACT超声评分系统的开发与验证:用于关节水平和患者水平焦磷酸钙晶体沉积范围的评估
本研究遵循OMERACT超声方法学,通过德尔菲调查制定焦磷酸钙沉积(CPPD)超声四等级半定量评分系统,并在静态图像和8例患者中检验信度。静态图像读片者内和读片者间信度几乎完美(κ 0.90和0.84),患者水平信度分别为0.72和0.66。该评分系统在静态图像和患者中均可靠,可能有助于临床试验和临床实践中监测晶体沉积范围。
要点
- 四等级半定量评分:0级无CPPD征象,1级≤3个单点或1个小沉积,2级>3个单点或>1个小沉积或≥1个较大沉积占据参考图像中检查结构≤50%,3级沉积占据参考图像中检查结构>50%。
- 评分应用于膝关节(半月板和透明软骨)和腕关节三角纤维软骨复合体。
- 静态图像读片者内信度κ 0.90(95%CI 0.79-1.00),读片者间信度κ 0.84(95%CI 0.79-0.88);8例患者中读片者内κ 0.72(95%CI 0.47-0.96),读片者间κ 0.66(95%CI 0.61-0.71)。
核心结论
- 该OMERACT超声CPPD评分系统在静态图像和患者中均可靠,可能成为临床试验中确保结果有效且可比的工具,并可能有助于临床实践中监测CPPD患者的晶体沉积范围。
研究设计与样本
- 本研究遵循已建立的OMERACT超声方法学,通过逐步流程开发CPPD新评分系统:先进行系统综述收集现有CPPD评分系统证据,再基于OMERACT超声工作组CPPD亚组成员专家意见进行德尔菲调查制定评分系统。
- 随后在基于网络和基于患者的练习中检验评分系统信度,使用加权Light κ系数评估读片者内和读片者间信度。
- 患者练习纳入8例患者(4例[50%]女性,4例[50%]男性)。
主要发现
- 制定的四等级半定量评分系统为:0级无CPPD征象;1级≤3个单点或1个小沉积;2级>3个单点或>1个小沉积或≥1个较大沉积占据参考图像中检查结构≤50%;3级沉积占据参考图像中检查结构>50%。
- 评分应应用于膝关节(半月板和透明软骨)和腕关节三角纤维软骨复合体。
- 静态图像读片者内信度κ 0.90(95%CI 0.79-1.00),读片者间信度κ 0.84(95%CI 0.79-0.88),几乎完美。
- 8例患者中读片者内信度κ 0.72(95%CI 0.47-0.96),读片者间信度κ 0.66(95%CI 0.61-0.71),信度显著。
关键数值与推荐
- CPPD超声评分系统四等级:0级无CPPD征象;1级≤3个单点或1个小沉积;2级>3个单点或>1个小沉积或≥1个较大沉积占据参考图像中检查结构≤50%;3级沉积占据参考图像中检查结构>50%。
- 评分应用于膝关节(半月板和透明软骨)和腕关节三角纤维软骨复合体。
- 静态图像读片者内信度κ 0.90(95%CI 0.79-1.00),读片者间信度κ 0.84(95%CI 0.79-0.88)。
- 患者读片者内信度κ 0.72(95%CI 0.47-0.96),读片者间信度κ 0.66(95%CI 0.61-0.71)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Calcium Pyrophosphate Deposition (CPPD) subgroup of the Outcome Measures in Rheumatology (OMERACT) Ultrasound working group was established to validate ultrasound as an outcome measure instrument for CPPD, and in 2017 has developed and validated standardised definitions for elementary lesions for the detection of calcium pyrophosphate crystals in joints. The aim of this study was to develop and evaluate the reliability of a consensus-based ultrasound scoring system for CPPD extent, representing the next phase in the OMERACT methodology. METHODS: In this study the novel scoring system for CPPD was developed through a stepwise process, following an established OMERACT ultrasound methodology. Following a previous systematic review to gather available evidence on existing scoring systems for CPPD, the novel scoring system was developed through a Delphi survey based on the expert opinion of the members of the OMERACT Ultrasound working group-CPPD subgroup. The reliability of the scoring system was then tested on a web-based and patient-based exercise. Intra-reader and inter-reader reliability of the new scoring system was assessed using weighted Light's κ coefficients. FINDINGS: The four-grade semiquantitative scoring system consisted of: grade 0 (no findings consistent with CPPD), grade 1 (≤3 single spots or 1 small deposit), grade 2 (>3 single spots or >1 small deposit or ≥1 larger deposit occupying ≤50% of the structure under examination in the reference image-ie, the scanning view with the highest grade of depositions), and grade 3 (deposits that occupy more than 50% of the structure under examination in the reference image). The score should be applied to the knee (menisci and hyaline cartilage) and the triangular fibrocartilage complex of the wrist. The intra-reader and inter-reader reliabilities on static images were almost perfect (κ 0·90 [95% CI 0·79-1·00] and κ 0·84 [0·79-0·88]), and on the eight patients recruited (four [50%] female and four [50%] male) were substantial (κ 0·72 [95% CI 0·47 to 0·96] and 0·66 [0·61 to 0·71]). INTERPRETATION: This OMERACT ultrasound scoring system for CPPD was reliable on both static images and patients. The scoring system might be a valuable tool for ensuring valid and comparable results in clinical trials and could help monitor the extent of crystal deposition in patients with CPPD in clinical practice. FUNDING: The Italian Ministry of Health - Ricerca Corrente.
引用
- Sirotti S, Terslev L, Filippucci E, et al. Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level. Lancet Rheumatol. 2023. PMID: 38251579. doi:10.1016/S2665-9913(23)00136-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。